Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Articles published by Cidara Therapeutics, Inc. Cidara Therapeutics to Present New Data for Rezafungin at IDWeek 2022 October 17, 2022 From Cidara Therapeutics, Inc. Via GlobeNewswire Tickers CDTX Cidara Therapeutics Receives $11.1 Million Milestone Payment from Mundipharma October 04, 2022 From Cidara Therapeutics, Inc. Via GlobeNewswire Tickers CDTX Cidara Therapeutics Submits NDA for Rezafungin and Announces License Agreement with Melinta Therapeutics for Commercialization of Rezafungin in the U.S. July 27, 2022 From Cidara Therapeutics, Inc. Via GlobeNewswire Tickers CDTX Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.